Envoy Medical (COCHW) Amortization of Deferred Charges (2024 - 2025)
Envoy Medical recorded quarterly Amortization of Deferred Charges of $4000.0 in Q4 2025, down 99.15% quarter-over-quarter from $468000.0 in Q3 2025, and down 98.96% year-over-year from $384000.0 in Q4 2024.
Envoy Medical's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $4000.0 for Q4 2025.
- In Q4 2025, Amortization of Deferred Charges fell 98.96% year-over-year to $4000.0; the TTM figure through Dec 2025 stood at $1.6 million (changed N/A YoY), while the FY2025 annual figure was $1.6 million, up 94.85% from the prior year.
- Amortization of Deferred Charges came in at $4000.0 for Q4 2025 at Envoy Medical, down from $468000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $623000.0 in Q2 2025 to a low of $4000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Envoy Medical | - | - | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 468,000.00 |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 623,000.00 |
| Jun 30, 2025 | 623,000.00 |
| Mar 31, 2025 | 495,000.00 |
| Mar 31, 2025 | 495,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Sep 30, 2024 | 264,000.00 |